Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
2022 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
11 intermediate papers

Works of Johanne Collin being referenced

Persistence and determinants of statin therapy among middle‐aged patients for primary and secondary prevention
2005
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease
2005

Author Peers

Author Last Decade Papers Cites
Johanne Collin 216 31 70 182 142 57 812
Benjamin F. Banahan 133 6 60 119 176 65 789
Katja Hermann 243 8 66 128 121 38 873
Zeba M. Khan 112 27 66 149 94 47 863
Cheryl P. Lynch 194 13 71 115 94 40 968
Janet Grime 373 7 58 73 184 24 804
Laura T. Pizzi 195 8 53 151 94 55 771
Ian Duncan 240 5 28 160 131 44 811
Rebecca Hanratty 226 11 89 79 76 32 917
Sally A. Huston 155 7 79 88 141 31 702
Helena Liira 145 10 37 73 96 47 651

All Works

Loading papers...

Rankless by CCL
2026